Cue Health Gets $28M Contract to Create Respiratory Multiplex Test for OTC and POC Use
Cue’s new test would differentiate between influenza A/B, RSV, and COVID simultaneously, with results delivered in approximately 25 minutes.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Respiratory Disease |
Cue’s new test would differentiate between influenza A/B, RSV, and COVID simultaneously, with results delivered in approximately 25 minutes.
Read MorePosted by Andy Lundin | Aug 2, 2023 | Covid 19 |
Scientists developed a breath test that quickly identifies those who are infected with the virus that causes COVID.
Read MorePosted by Andy Lundin | Aug 1, 2023 | Cancer |
A new study from researchers at the ACS found monthly adult cancer diagnoses decreased by half in April 2020 in the United States.
Read MorePosted by Andy Lundin | Aug 1, 2023 | Covid 19 |
SEKISUI Diagnostics announced the launch of the OSOM COVID-19 Antigen Home Test to diagnose COVID-19 at home.
Read MorePosted by Andy Lundin | Jul 31, 2023 | Covid 19, Flu & Respiratory Infections |
The new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
Read More